India  

Centre gives nod for Rs 4,500 crore credit support for SII, Bharat Biotech to boost COVID-19 vaccine production

DNA Monday, 19 April 2021 ()
The financial support came as the government decided to open up vaccination for all citizens above the age of 18 from May 1.
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin 01:14

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to...

You Might Like


💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Bharat Biotech responds to Delhi's Covaxin plea, says...|  Oneindia News [Video]

Bharat Biotech responds to Delhi's Covaxin plea, says...| Oneindia News

Covaxin's maker Bharat Biotech has refused to supply vaccine doses to Delhi, Deputy Chief Minister Manish Sisodia said today. Cong MP Rahul Gandhi hit out at the centre's push for positivity aid the covid crisis in India, calling it betrayal. Sinovac Biotech Ltd.'s vaccine is wiping out Covid-19 among health workers in Indonesia, a study shows. All this and more news at 2 PM. #Covaxin #Israel #Sinovac

Credit: Oneindia    Duration: 03:17Published

Bharat Biotech's Covaxin recommended by expert panel for phase 2/3 trials on 2-18 year-olds

Bharat Biotech's Covid-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years,..
IndiaTimes

Bharat Biotech commences direct supply of 'Covaxin' to 14 states

The company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana,..
IndiaTimes

COVID-19: Bharat Biotech's Covaxin approved by Centre for children above 12 years? Government said THIS

The tweet shared by PIB also shared a screenshot of the news that claimed that Covaxin has been approved for children.
DNA

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

CDC panel clears way for COVID vaccines for adolescents [Video]

CDC panel clears way for COVID vaccines for adolescents

U.S. states are set to begin using the vaccine from Pfizer and BioNTech to inoculate young adolescents against COVID-19 after advisers to the U.S. Centers for Disease Control and Prevention (CDC) backed the plan in a unanimous vote on Wednesday. Freddie Joyner has more.

Credit: Reuters - Politics    Duration: 02:00Published
CDC advisers endorse Pfizer COVID-19 vaccine for kids 12 and up [Video]

CDC advisers endorse Pfizer COVID-19 vaccine for kids 12 and up

A group of immunization experts have given their recommendation for kids as young as 12 to get Pfizer's COVID-19 vaccine.

Credit: ABC Action News    Duration: 02:09Published

3.5 lakh fresh Covid cases, toll over 4k for 2nd day in a row

After remaining low for two consecutive days, fresh cases again breached the 3.5 lakh benchmark on Wednesday. Deaths also remained over 4,000 for the second day..
IndiaTimes

Related videos from verified sources

Covid: SII reduces Covishield price, vaccine now at Rs 300 per dose for states [Video]

Covid: SII reduces Covishield price, vaccine now at Rs 300 per dose for states

Serum Institute of India reduced the vaccine price for the state government from Rs 400 per dose to Rs 300 per dose. SII chairman Adar Poonawalla announced on Twitter a reduction in prices...

Credit: HT Digital Content     Duration: 01:27Published
Centre asks Serum Institute, Bharat Biotech to lower Covid vaccines’ price [Video]

Centre asks Serum Institute, Bharat Biotech to lower Covid vaccines’ price

The central government on Monday asked the Serum Institute and Bharat Biotech to lower price of their COVID-19 vaccines amid criticism from various states who accused the companies of profiteering..

Credit: HT Digital Content     Duration: 01:28Published